These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10589545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG.
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [Abstract] [Full Text] [Related]

  • 5. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
    Poetsch M, Lorenz G, Kleist B.
    Cancer Genet Cytogenet; 2002 Jan 01; 132(1):20-4. PubMed ID: 11801303
    [Abstract] [Full Text] [Related]

  • 6. Microsatellite instability, PTEN and p53 germline mutations in glioma families.
    Malmer B, Grönberg H, Andersson U, Jonsson BA, Henriksson R.
    Acta Oncol; 2001 Jan 01; 40(5):633-7. PubMed ID: 11669337
    [Abstract] [Full Text] [Related]

  • 7. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y, Pang JC, Ng HK, Ding M, Zhang SF, Zheng J, Liu DG, Poon WS.
    Histopathology; 2000 Nov 01; 37(5):437-44. PubMed ID: 11119125
    [Abstract] [Full Text] [Related]

  • 8. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han SY, Suzuki T, Shibata H, Kanamaru R, Ishioka C.
    Clin Cancer Res; 2000 Oct 01; 6(10):3937-43. PubMed ID: 11051241
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M.
    Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005
    [Abstract] [Full Text] [Related]

  • 11. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C, Joyce KA, Thompson-Hehir J, Davies MP, Gibbs FE, Halliwell N, Lloyd BH, Machell Y, Roebuck MM, Salisbury J, Sibson DR, Du Plessis D, Broome J, Rossi ML.
    Acta Neuropathol; 2001 Apr 15; 101(4):321-33. PubMed ID: 11355303
    [Abstract] [Full Text] [Related]

  • 12. The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies.
    Fueyo J, Gomez-Manzano C, Yung WK, Kyritsis AP.
    Neurology; 1998 Nov 15; 51(5):1250-5. PubMed ID: 9818841
    [Abstract] [Full Text] [Related]

  • 13. Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
    Stankovic T, Milinkovic V, Bankovic J, Dinic J, Tanic N, Dramicanin T, Tanic N.
    Biomed Pharmacother; 2014 Jun 15; 68(5):521-6. PubMed ID: 24767865
    [Abstract] [Full Text] [Related]

  • 14. Detection and Correlation of Single and Concomitant TP53, PTEN, and CDKN2A Alterations in Gliomas.
    Pessôa IA, Amorim CK, Ferreira WAS, Sagica F, Brito JR, Othman M, Meyer B, Liehr T, de Oliveira EHC.
    Int J Mol Sci; 2019 May 30; 20(11):. PubMed ID: 31151164
    [Abstract] [Full Text] [Related]

  • 15. Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li-Fraumeni syndrome.
    Burt EC, McGown G, Thorncroft M, James LA, Birch JM, Varley JM.
    Br J Cancer; 1999 Apr 30; 80(1-2):9-10. PubMed ID: 10389970
    [Abstract] [Full Text] [Related]

  • 16. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
    Tsao H, Zhang X, Fowlkes K, Haluska FG.
    Cancer Res; 2000 Apr 01; 60(7):1800-4. PubMed ID: 10766161
    [Abstract] [Full Text] [Related]

  • 17. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D, Pedone C.
    Neuro Oncol; 2000 Apr 01; 2(2):71-9. PubMed ID: 11303623
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetic analysis of phosphatase and tensin homolog and p16 tumor suppressor genes in patients with malignant glioma.
    Abdullah JM, Zainuddin N, Sulong S, Jaafar H, Isa MN.
    Neurosurg Focus; 2003 Apr 15; 14(4):e6. PubMed ID: 15679305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.
    Ushio Y, Tada K, Shiraishi S, Kamiryo T, Shinojima N, Kochi M, Saya H.
    Front Biosci; 2003 May 01; 8():e281-8. PubMed ID: 12700122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.